NURS 6521 Midterm V2 | NURS 6521
Advanced Pharmacology | Actual Q&A
with Rationale (NURS6521 Midterm) |
Walden University
1. A patient with chronic renal failure requires a medication that is primarily excreted by the
kidneys. Which pharmacokinetic adjustment should the Advanced Practice Nurse (APN)
prioritize?
A. Increase the loading dose to reach steady state faster.
B. Switch to an oral route to delay absorption.
C. Decrease the maintenance dose or increase the dosing interval.
D. Administer the drug alongside a diuretic to enhance clearance.
Answer: C
Rationale: In patients with renal impairment, the clearance of drugs excreted via the
kidneys is significantly reduced. Failure to adjust the dosage leads to drug accumulation
and potential toxicity. The APN must utilize the glomerular filtration rate (GFR) or
creatinine clearance to determine the appropriate reduction in dose or extension of the
interval between doses.
,2. When prescribing a drug that is a known substrate of the Cytochrome P450 3A4 enzyme
system, the APN observes the patient is also taking a known 3A4 inducer. What is the most
likely clinical outcome?
A. The substrate drug will reach toxic levels in the blood.
B. The substrate drug will experience a prolonged half-life.
C. The substrate drug will have decreased therapeutic efficacy.
D. The metabolic rate of the inducer will be inhibited.
Answer: C
Rationale: Inducers of the CYP450 system increase the metabolic activity of specific
enzymes, leading to faster breakdown of substrate drugs. This rapid metabolism results in
lower plasma concentrations of the substrate, potentially falling below the minimum
effective concentration. Consequently, the patient may not achieve the desired therapeutic
effect from the medication.
3. An elderly patient is prescribed a highly lipophilic medication. How do age-related changes
in body composition affect the distribution of this drug?
A. Increased body fat percentage leads to a larger volume of distribution and prolonged
half-life.
B. Increased lean muscle mass leads to rapid clearance.
C. Decreased total body water causes immediate toxicity.
D. Reduced albumin levels lead to decreased free drug concentration.
,Answer: A
Rationale: Aging is associated with an increase in adipose tissue and a decrease in lean
body mass and total body water. Lipophilic drugs distribute extensively into fat stores,
which acts as a reservoir in elderly patients. This results in a prolonged elimination half-
life, increasing the risk for cumulative toxicity over time.
4. Which statement best describes the ‘First-Pass Effect’ in pharmacology?
A. The initial phase of drug distribution to highly vascularized organs.
B. The metabolism of a drug by the liver before it reaches systemic circulation.
C. The rapid excretion of a drug by the kidneys immediately after administration.
D. The binding of a drug to plasma proteins upon entering the bloodstream.
Answer: B
Rationale: The first-pass effect occurs when an orally administered drug is absorbed from
the gastrointestinal tract and enters the portal circulation. The liver metabolizes a portion
of the drug before it can enter the general systemic circulation. This phenomenon
significantly reduces the bioavailability of certain medications, requiring higher oral doses
compared to intravenous doses.
5. The APN is considering the therapeutic index (TI) of a new medication. Which TI value
indicates the greatest need for close serum drug level monitoring?
A. TI = 100
B. TI = 2
, C. TI = 50
D. TI = 20
Answer: B
Rationale: The therapeutic index is a ratio that compares the blood concentration at which
a drug becomes toxic to the concentration at which the drug is effective. A narrow
therapeutic index, represented by a small numerical value, indicates that the margin
between safety and toxicity is slim. Drugs with a narrow TI, such as digoxin or lithium,
require frequent blood monitoring to ensure patient safety.
6. A patient is diagnosed with a bacterial infection and prescribed an aminoglycoside. The
APN should monitor for which specific adverse effects?
A. Ototoxicity and nephrotoxicity
B. Hepatotoxicity and tendon rupture
C. Photosensitivity and dental staining
D. Peripheral neuropathy and visual disturbances.
Answer: A
Rationale: Aminoglycosides are potent antibiotics known for their narrow therapeutic
range and specific organ toxicities. They can accumulate in the inner ear and the renal
proximal tubules, leading to permanent hearing loss or acute kidney injury. Monitoring
serum trough levels and renal function tests is mandatory during therapy.
Advanced Pharmacology | Actual Q&A
with Rationale (NURS6521 Midterm) |
Walden University
1. A patient with chronic renal failure requires a medication that is primarily excreted by the
kidneys. Which pharmacokinetic adjustment should the Advanced Practice Nurse (APN)
prioritize?
A. Increase the loading dose to reach steady state faster.
B. Switch to an oral route to delay absorption.
C. Decrease the maintenance dose or increase the dosing interval.
D. Administer the drug alongside a diuretic to enhance clearance.
Answer: C
Rationale: In patients with renal impairment, the clearance of drugs excreted via the
kidneys is significantly reduced. Failure to adjust the dosage leads to drug accumulation
and potential toxicity. The APN must utilize the glomerular filtration rate (GFR) or
creatinine clearance to determine the appropriate reduction in dose or extension of the
interval between doses.
,2. When prescribing a drug that is a known substrate of the Cytochrome P450 3A4 enzyme
system, the APN observes the patient is also taking a known 3A4 inducer. What is the most
likely clinical outcome?
A. The substrate drug will reach toxic levels in the blood.
B. The substrate drug will experience a prolonged half-life.
C. The substrate drug will have decreased therapeutic efficacy.
D. The metabolic rate of the inducer will be inhibited.
Answer: C
Rationale: Inducers of the CYP450 system increase the metabolic activity of specific
enzymes, leading to faster breakdown of substrate drugs. This rapid metabolism results in
lower plasma concentrations of the substrate, potentially falling below the minimum
effective concentration. Consequently, the patient may not achieve the desired therapeutic
effect from the medication.
3. An elderly patient is prescribed a highly lipophilic medication. How do age-related changes
in body composition affect the distribution of this drug?
A. Increased body fat percentage leads to a larger volume of distribution and prolonged
half-life.
B. Increased lean muscle mass leads to rapid clearance.
C. Decreased total body water causes immediate toxicity.
D. Reduced albumin levels lead to decreased free drug concentration.
,Answer: A
Rationale: Aging is associated with an increase in adipose tissue and a decrease in lean
body mass and total body water. Lipophilic drugs distribute extensively into fat stores,
which acts as a reservoir in elderly patients. This results in a prolonged elimination half-
life, increasing the risk for cumulative toxicity over time.
4. Which statement best describes the ‘First-Pass Effect’ in pharmacology?
A. The initial phase of drug distribution to highly vascularized organs.
B. The metabolism of a drug by the liver before it reaches systemic circulation.
C. The rapid excretion of a drug by the kidneys immediately after administration.
D. The binding of a drug to plasma proteins upon entering the bloodstream.
Answer: B
Rationale: The first-pass effect occurs when an orally administered drug is absorbed from
the gastrointestinal tract and enters the portal circulation. The liver metabolizes a portion
of the drug before it can enter the general systemic circulation. This phenomenon
significantly reduces the bioavailability of certain medications, requiring higher oral doses
compared to intravenous doses.
5. The APN is considering the therapeutic index (TI) of a new medication. Which TI value
indicates the greatest need for close serum drug level monitoring?
A. TI = 100
B. TI = 2
, C. TI = 50
D. TI = 20
Answer: B
Rationale: The therapeutic index is a ratio that compares the blood concentration at which
a drug becomes toxic to the concentration at which the drug is effective. A narrow
therapeutic index, represented by a small numerical value, indicates that the margin
between safety and toxicity is slim. Drugs with a narrow TI, such as digoxin or lithium,
require frequent blood monitoring to ensure patient safety.
6. A patient is diagnosed with a bacterial infection and prescribed an aminoglycoside. The
APN should monitor for which specific adverse effects?
A. Ototoxicity and nephrotoxicity
B. Hepatotoxicity and tendon rupture
C. Photosensitivity and dental staining
D. Peripheral neuropathy and visual disturbances.
Answer: A
Rationale: Aminoglycosides are potent antibiotics known for their narrow therapeutic
range and specific organ toxicities. They can accumulate in the inner ear and the renal
proximal tubules, leading to permanent hearing loss or acute kidney injury. Monitoring
serum trough levels and renal function tests is mandatory during therapy.
